327 related articles for article (PubMed ID: 27809351)
21. Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
Kornstein SG; Jiang Q; Reddy S; Musgnung JJ; Guico-Pabia CJ
J Clin Psychiatry; 2010 Aug; 71(8):1088-96. PubMed ID: 20797382
[TBL] [Abstract][Full Text] [Related]
22. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
23. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.
Ashman TA; Cantor JB; Gordon WA; Spielman L; Flanagan S; Ginsberg A; Engmann C; Egan M; Ambrose F; Greenwald B
Arch Phys Med Rehabil; 2009 May; 90(5):733-40. PubMed ID: 19406291
[TBL] [Abstract][Full Text] [Related]
24. Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study.
Rezaei F; Mohammad-Karimi M; Seddighi S; Modabbernia A; Ashrafi M; Salehi B; Hammidi S; Motasami H; Hajiaghaee R; Tabrizi M; Akhondzadeh S
J Clin Psychopharmacol; 2013 Jun; 33(3):336-42. PubMed ID: 23609382
[TBL] [Abstract][Full Text] [Related]
25. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
Isaac MT; Isaac MB; Gallo F; Tournoux A
Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
[TBL] [Abstract][Full Text] [Related]
26. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
Muhonen LH; Lönnqvist J; Juva K; Alho H
J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597
[TBL] [Abstract][Full Text] [Related]
27. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
28. l-theanine adjunct to sertraline for major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial.
Shamabadi A; Kafi F; Arab Bafrani M; Asadigandomani H; A Basti F; Akhondzadeh S
J Affect Disord; 2023 Jul; 333():38-43. PubMed ID: 37084960
[TBL] [Abstract][Full Text] [Related]
29. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
[TBL] [Abstract][Full Text] [Related]
30. The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression: a randomized, double-blind, placebo-controlled study.
Bloch M; Meiboom H; Lorberblatt M; Bluvstein I; Aharonov I; Schreiber S
J Clin Psychiatry; 2012 Feb; 73(2):235-41. PubMed ID: 22401479
[TBL] [Abstract][Full Text] [Related]
31. Citicoline Combination Therapy for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Roohi-Azizi M; Arabzadeh S; Amidfar M; Salimi S; Zarindast MR; Talaei A; Akhondzadeh S
Clin Neuropharmacol; 2017; 40(1):1-5. PubMed ID: 28085707
[TBL] [Abstract][Full Text] [Related]
32. Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study.
Ghaleiha A; Entezari N; Modabbernia A; Najand B; Askari N; Tabrizi M; Ashrafi M; Hajiaghaee R; Akhondzadeh S
J Psychiatr Res; 2013 Feb; 47(2):175-80. PubMed ID: 23063327
[TBL] [Abstract][Full Text] [Related]
33. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial.
Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K
Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706
[TBL] [Abstract][Full Text] [Related]
34. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
; Davidson JR; Gadde KM; Fairbank JA; Krishnan KRR; Califf RM; Binanay C; Parker CB; Pugh N; Hartwell TD; Vitiello B; Ritz L; Severe J; Cole JO; de Battista C; Doraiswamy PM; Feighner JP; Keck P; Kelsey J; Lin KM; Londborg PD; Nemeroff CB; Schatzberg AF; Sheehan DV; Srivastava RK; Taylor L; Trivedi MH; Weisler RH
JAMA; 2002 Apr; 287(14):1807-14. PubMed ID: 11939866
[TBL] [Abstract][Full Text] [Related]
35. A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia.
Lieberman JA; Papadakis K; Csernansky J; Litman R; Volavka J; Jia XD; Gage A;
Neuropsychopharmacology; 2009 Apr; 34(5):1322-9. PubMed ID: 19005465
[TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older.
Finkel SI; Richter EM; Clary CM
Int Psychogeriatr; 1999 Mar; 11(1):85-99. PubMed ID: 10189602
[TBL] [Abstract][Full Text] [Related]
37. Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.
Kulkarni J; Thomas N; Hudaib AR; Gavrilidis E; Grigg J; Tan R; Cheng J; Arnold A; Gurvich C
CNS Drugs; 2018 Feb; 32(2):179-187. PubMed ID: 29549516
[TBL] [Abstract][Full Text] [Related]
38. Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial.
Yildiz A; Mantar A; Simsek S; Onur E; Gökmen N; Fidaner H
J ECT; 2010 Jun; 26(2):104-10. PubMed ID: 19935091
[TBL] [Abstract][Full Text] [Related]
39. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
40. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]